253 related articles for article (PubMed ID: 36979584)
1. Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients' Follow Up.
Borriello M; Tarabella G; D'Angelo P; Liboà A; Barra M; Vurro D; Lombari P; Coppola A; Mazzella E; Perna AF; Ingrosso D
Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979584
[TBL] [Abstract][Full Text] [Related]
2. Implementation of point-of-care testing in a pediatric healthcare setting.
Patel K; Suh-Lailam BB
Crit Rev Clin Lab Sci; 2019 Jun; 56(4):239-246. PubMed ID: 30973797
[TBL] [Abstract][Full Text] [Related]
3. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
4. Association of Chronic Kidney Disease With In-Hospital Outcomes of Transcatheter Aortic Valve Replacement.
Gupta T; Goel K; Kolte D; Khera S; Villablanca PA; Aronow WS; Bortnick AE; Slovut DP; Taub CC; Kizer JR; Pyo RT; Abbott JD; Fonarow GC; Rihal CS; Garcia MJ; Bhatt DL
JACC Cardiovasc Interv; 2017 Oct; 10(20):2050-2060. PubMed ID: 29050621
[TBL] [Abstract][Full Text] [Related]
5. Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Grams ME; Yang W; Rebholz CM; Wang X; Porter AC; Inker LA; Horwitz E; Sondheimer JH; Hamm LL; He J; Weir MR; Jaar BG; Shafi T; Appel LJ; Hsu CY;
Am J Kidney Dis; 2017 Sep; 70(3):337-346. PubMed ID: 28366517
[TBL] [Abstract][Full Text] [Related]
6. Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.
Faria M; de Pinho MN
Transl Res; 2021 Mar; 229():115-134. PubMed ID: 32891787
[TBL] [Abstract][Full Text] [Related]
7. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
[TBL] [Abstract][Full Text] [Related]
8. Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries.
Charytan DM; Natwick T; Solid CA; Li S; Gong T; Herzog CA
Am J Kidney Dis; 2019 Oct; 74(4):463-473. PubMed ID: 31255335
[TBL] [Abstract][Full Text] [Related]
9. Detection of renal biomarkers in chronic kidney disease using microfluidics: progress, challenges and opportunities.
Liu KZ; Tian G; Ko AC; Geissler M; Brassard D; Veres T
Biomed Microdevices; 2020 Apr; 22(2):29. PubMed ID: 32318839
[TBL] [Abstract][Full Text] [Related]
10. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
Kumar A; Parihar A; Panda U; Parihar DS
ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
[TBL] [Abstract][Full Text] [Related]
11. Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets.
Lim YJ; Sidor NA; Tonial NC; Che A; Urquhart BL
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33668632
[TBL] [Abstract][Full Text] [Related]
12. [Lab on a Chip].
Drese KS
Internist (Berl); 2019 Apr; 60(4):339-344. PubMed ID: 30506152
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease and its relationship with chronic kidney disease.
Liu M; Li XC; Lu L; Cao Y; Sun RR; Chen S; Zhang PY
Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2918-26. PubMed ID: 25339487
[TBL] [Abstract][Full Text] [Related]
14. Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
Weir MR; Fink JC
Curr Opin Nephrol Hypertens; 2014 May; 23(3):306-13. PubMed ID: 24670404
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary Hypertension, Mortality, and Cardiovascular Disease in CKD and ESRD Patients: A Systematic Review and Meta-analysis.
Tang M; Batty JA; Lin C; Fan X; Chan KE; Kalim S
Am J Kidney Dis; 2018 Jul; 72(1):75-83. PubMed ID: 29429751
[TBL] [Abstract][Full Text] [Related]
16. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
[TBL] [Abstract][Full Text] [Related]
17. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
18. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
19. Racial differences in renal replacement therapy initiation among children with a nonglomerular cause of chronic kidney disease.
Ng DK; Moxey-Mims M; Warady BA; Furth SL; Muñoz A
Ann Epidemiol; 2016 Nov; 26(11):780-787.e1. PubMed ID: 27789133
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
